Uptake by Hepatocytes and Biliary Excretion of Intravenously Administered Polystyrene Microspheres in Rats
- 1 January 1999
- journal article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 7 (3) , 213-221
- https://doi.org/10.3109/10611869909085504
Abstract
The in vivo uptake by hepatocytes and biliary excretion of fluorescein isothiocyanate-labeled polystyrene microsphere with a particle size of 50 nm (MS-50) after intravenous administration was studied in rats. It was confirmed by using confocal laser scanning microscopy that MS-50 was partially phagocytosed by the hepatocytes and that MS-50 taken up by the hepatocytes existed exclusively inside the cells 1 h after intravenous administration. Studies on the mechanism of the uptake of MS-50 by the hepatocytes using the liver perfusion technique revealed that a process mediated by apo-E was involved. After intravenous administration of MS-50, about 4% of dose was excreted into bile in 24 h. Pharmacokinetic evaluation of the excretion rate of MS-50 into bile showed that the process followed first-order kinetics. Qualitative evaluation of the fluorescence detected in the bile after intravenous administration of MS-50 revealed that the particles were certainly excreted into bile in an intact form. From these results, it was suggested that intravenously administered MS-50 would be partially phagocytosed by hepatocytes through a process mediated by apo-E and that MS-50 ingested by hepatocytes would be partially excreted into the bile.Keywords
This publication has 18 references indexed in Scilit:
- Pharmacokinetic Evaluation of Mannosylated Bovine Serum Albumin as a Liver Cell-Specific Carrier: Quantitative Comparison with Other Hepatotropic LigandsJournal of Drug Targeting, 1999
- Recognition and clearance of liposomes containing phosphatidylserine are mediated by serum opsoninBiochimica et Biophysica Acta (BBA) - Biomembranes, 1995
- Lipid Nano-Sphere(LNS), a protein-free analogue of lipoproteins, as a novel drug carrier for parenteral administration. IVJournal of Controlled Release, 1994
- The Complement- but not Mannose Receptor-Mediated Phagocytosis is Involved in the Hepatic Uptake of Cetylmannoside-Modified LiposomesIn SituJournal of Drug Targeting, 1994
- Recent clinical studies on lipo-PGE1 and lipo-PGI2: PGE1 and PGI2 incorporated in lipid microspheres, for targeted deliveryJournal of Controlled Release, 1994
- Uptake of toxic silica particles by isolated rat liver macrophages (Kupffer cells) is receptor mediated and can be blocked by competition.Journal of Clinical Investigation, 1992
- Evidence that hepatocytes can phagocytize exogenous substancesThe Anatomical Record, 1992
- Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1992
- Receptor-mediated biliary transport of immunoglobulin A and asialoglycoprotein: sorting and missorting of ligands revealed by two radiolabeling methods.The Journal of cell biology, 1984
- Statistical moments in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1978